Results 221 to 230 of about 64,482 (277)
Some of the next articles are maybe not open access.
Clinical Pharmacology & Therapeutics, 1978
I wish to point out a significant error in the article by Peter W. Mullen, “Optimal phenytoin therapy: A new technique for individualizing dosage,” which appeared on page 228 of the February, 1978, issue of the Journal. In Table I, the serum phenytoin concentrations he predicted by using the method described by Ludden and colleagues (Clin.
openaire +2 more sources
I wish to point out a significant error in the article by Peter W. Mullen, “Optimal phenytoin therapy: A new technique for individualizing dosage,” which appeared on page 228 of the February, 1978, issue of the Journal. In Table I, the serum phenytoin concentrations he predicted by using the method described by Ludden and colleagues (Clin.
openaire +2 more sources
Neurocritical Care, 2005
Phenytoin toxicity may result from intentional overdose, dosage adjustments, drug interactions, or alterations in physiology. Intoxication manifests predominantly as nausea, central nervous system dysfunction (particularly confusion, nystagmus, and ataxia), with depressed conscious state, coma, and seizures occurring in more severe cases.
openaire +2 more sources
Phenytoin toxicity may result from intentional overdose, dosage adjustments, drug interactions, or alterations in physiology. Intoxication manifests predominantly as nausea, central nervous system dysfunction (particularly confusion, nystagmus, and ataxia), with depressed conscious state, coma, and seizures occurring in more severe cases.
openaire +2 more sources
Reactions Weekly, 2018
Phenytoin is a first-generation antiepileptic drug characterized by a good range of antiepileptic indications, with an acceptable interaction profile in polytherapy. The reasons for the decreased use of phenytoin in patients with epilepsy include its narrow therapeutic index and potential for long-term toxicity, as well as the development of other ...
openaire +2 more sources
Phenytoin is a first-generation antiepileptic drug characterized by a good range of antiepileptic indications, with an acceptable interaction profile in polytherapy. The reasons for the decreased use of phenytoin in patients with epilepsy include its narrow therapeutic index and potential for long-term toxicity, as well as the development of other ...
openaire +2 more sources
Journal of Allergy and Clinical Immunology, 1980
S H, Josephs, S J, Rothman, R H, Buckley
openaire +2 more sources
S H, Josephs, S J, Rothman, R H, Buckley
openaire +2 more sources